eSpCas9-hGeminin
(Plasmid
#199344)
-
Purposemodified version of the eSpCas9(1.1)_No_FLAG_ATP1A1_G3_Dual_sgRNA plasmid (addgene #86613) where the C-terminus of the eSpCas9 enzyme was fused to amino acids 1 – 110 of human Geminin
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 199344 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepX330-U6-Chimeric_BB-CBh-hSpCas9
- Total vector size (bp) 9188
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameATP1A1 G3 sgRNA+user-specified sgRNA+enhanced specificity Cas9 (1.1) (addgene 86613) with cas9 fused to hgem fragment 1-110)
-
SpeciesS. pyogenes
-
Insert Size (bp)9188
-
Mutationcas9 c-term fused to hgemenin 1-110 fragment
-
Entrez GeneGMNN (a.k.a. Gem, MGORS6)
- Promoter cbh
-
Tag
/ Fusion Protein
- cas9 c-term fused to hgemenin 1-110 fragment (C terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer GCAGACAAATGGCTCTAGCTG
- 3′ sequencing primer CAGCTAGAGCCATTTGTCTGC (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byAddgene 86613 (eSpCas9(1.1)_No_FLAG_ATP1A1_G3_Dual_sgRNA) https://www.addgene.org/86613/
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
eSpCas9-hGeminin was a gift from Iain Hagan (Addgene plasmid # 199344 ; http://n2t.net/addgene:199344 ; RRID:Addgene_199344) -
For your References section:
Elevated basal AMP-activated protein kinase activity sensitizes colorectal cancer cells to growth inhibition by metformin. Morrison KR, Wang T, Chan KY, Trotter EW, Gillespie A, Michael MZ, Oakhill JS, Hagan IM, Petersen J. Open Biol. 2023 Apr;13(4):230021. doi: 10.1098/rsob.230021. Epub 2023 Apr 12. 10.1098/rsob.230021 PubMed 37042113